Target intelligence / Profile preview

N-deacetylase and N-sulfotransferase 2 (NDST2)

Target
NDST2
Molecular classification
Enzyme, Transferase (specifically, sulfotransferase), Glycosaminoglycan biosynthesis enzyme
01

Overview

N-deacetylase and N-sulfotransferase 2 (NDST2) is a bifunctional enzyme critical for the biosynthesis of heparan sulfate, a key glycosaminoglycan in animal tissues. NDST2 catalyzes two essential modifications: the N-deacetylation and N-sulfation of glucosamine residues within heparan sulfate precursors, enabling the polymer to serve as a substrate for further enzymatic processing and functional diversification. NDST2 is essential for controlling both the *quantity* and *structural pattern* of heparan sulfate by regulating chain elongation and the introduction of N-sulfate groups. It is especially important for heparin biosynthesis in mast cells, and its deficiency leads to abnormal mast cell phenotype and changes in connective tissue, but does not cause early lethality in mice (unlike the related NDST1 isoform). NDST2 is classified as a sulfotransferase and transferase enzyme, and is localized primarily to the Golgi apparatus. Clinical gene associations include rare connective tissue and bone disorders. There are currently no drugs specifically approved or recognized as interacting with NDST2, and its manipulation poses risks due to its broad role in extracellular matrix biology and tissue homeostasis.

Other names
Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2Heparan sulfate N-deacetylase 2Heparan sulfate N-sulfotransferase 2HSST2NDST-2N-HSST 2NST2glucosaminyl N-deacetylase/N-sulfotransferase 2N-heparan sulfate sulfotransferase 2
02

Mechanism of action

Not applicable; no drugs specifically targeting NDST2 identified in search results. Hypothetically, inhibitors would reduce heparan sulfate N-sulfation and chain elongation.

03

Biological functions

Heparan sulfate biosynthesisPolymer processing of glucosamine and heparinN-deacetylation of glucosamine residuesN-sulfation of glucosamine residuesRegulation of heparan sulfate chain length and sulfation pattern
04

Disease associations

Connective tissue disorders (e.g., abnormal mast cell function)Synostoses, tarsal, carpal, and digitalEhlers-Danlos syndrome, musculocontractural typePotential broader relevance in diseases involving heparan sulfate, but direct links to cancer, inflammation, etc., are limited in current data
05

Safety considerations

Potential risk for broad effects on glycosaminoglycan structure and tissue homeostasis if inhibitedPossible alteration of connective tissue or mast cell function (as seen in Ndst2 knockout mice)

Beyond the preview

Go deeper on N-deacetylase and N-sulfotransferase 2 (NDST2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-deacetylase and N-sulfotransferase 2 (NDST2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call